Abstract
The bacteriostatic and bactericidal activities of 24 antimicrobial agents were tested with the Dynatech MIC 2000 system against 86 strains of Campylobacter fetus subsp. jejuni from human sources. The penicillins (penicillin G, ampicillin, amoxycillin, carbenicillin) had poor activity. Ampicillin and amoxycillin were equally active. Cefotaxime revealed a rather good activity. Erythromycin, gentamicin, tobramycin, amikacin, and furazolidone were the most active compounds. Two strains (2.3%) were resistant to erythromycin. One strain (1.2%) was completely resistant to tobramycin. The tetracyclines (tetracyline, doxycycline, minocycline) were generally effective, but 8% of the strains were totally resistant to them. Minocycline was the most active. Chloramphenicol, thiamphenicol, and clindamycin had good activity. The bacteriostatic and bactericidal distributions for colistin, nalidixic acid, and metronidazole were broad.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Butzler J. P., Dekeyser P., Lafontaine T. Susceptibility of related vibrios and Vibrio fetus to twelve antibiotics. Antimicrob Agents Chemother. 1974 Jan;5(1):86–89. doi: 10.1128/aac.5.1.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Butzler J. P., Skirrow M. B. Campylobacter enteritis. Acta Paediatr Belg. 1979 Apr-Jun;32(2):89–94. [PubMed] [Google Scholar]
- Chow A. W., Patten V., Bednorz D. Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents. Antimicrob Agents Chemother. 1978 Mar;13(3):416–418. doi: 10.1128/aac.13.3.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davies J. S., Penfold J. B. Campylobacter urinary infection. Lancet. 1979 May 19;1(8125):1091–1092. doi: 10.1016/s0140-6736(79)92995-7. [DOI] [PubMed] [Google Scholar]
- De Mol P., Bosmans E. Campylobacter enteritis in Central Africa. Lancet. 1978 Mar 18;1(8064):604–604. doi: 10.1016/s0140-6736(78)91044-9. [DOI] [PubMed] [Google Scholar]
- Dekeyser P., Gossuin-Detrain M., Butzler J. P., Sternon J. Acute enteritis due to related vibrio: first positive stool cultures. J Infect Dis. 1972 Apr;125(4):390–392. doi: 10.1093/infdis/125.4.390. [DOI] [PubMed] [Google Scholar]
- KING E. O. Human infections with Vibrio fetus and a closely related vibrio. J Infect Dis. 1957 Sep-Oct;101(2):119–128. doi: 10.1093/infdis/101.2.119. [DOI] [PubMed] [Google Scholar]
- Karmali M. A., Fleming P. C. Campylobacter enteritis in children. J Pediatr. 1979 Apr;94(4):527–533. doi: 10.1016/s0022-3476(79)80004-9. [DOI] [PubMed] [Google Scholar]
- Lauwers S., De Boeck M., Butzler J. P. Campylobacter enteritis in Brussels. Lancet. 1978 Mar 18;1(8064):604–605. doi: 10.1016/s0140-6736(78)91045-0. [DOI] [PubMed] [Google Scholar]
- Lüthy R., Münch R., Blaser J., Bhend H., Siegenthaler W. Human pharmacology of cefotaxime (HR 756), a new cephalosporin. Antimicrob Agents Chemother. 1979 Aug;16(2):127–133. doi: 10.1128/aac.16.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mertens A., De Smet M. Campylobacter cholecystitis. Lancet. 1979 May 19;1(8125):1092–1093. doi: 10.1016/s0140-6736(79)92997-0. [DOI] [PubMed] [Google Scholar]
- Severin W. P. Campylobacter en enteritis. Ned Tijdschr Geneeskd. 1978 Apr 15;122(15):499–504. [PubMed] [Google Scholar]
- Skirrow M. B. Campylobacter enteritis: a "new" disease. Br Med J. 1977 Jul 2;2(6078):9–11. doi: 10.1136/bmj.2.6078.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vanhoff R., Butzler J. P., Yourassowsky E. In-vitro activity of new cephalosporin (HR 756) and cefazolin. Lancet. 1978 Jul 22;2(8082):209–210. doi: 10.1016/s0140-6736(78)91951-7. [DOI] [PubMed] [Google Scholar]
- Vanhoof R., Vanderlinden M. P., Dierickx R., Lauwers S., Yourassowsky E., Butzler J. P. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother. 1978 Oct;14(4):553–556. doi: 10.1128/aac.14.4.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walder M., Forsgren A. Erythromycin-resistant Campylobacters. Lancet. 1978 Dec 2;2(8101):1201–1201. doi: 10.1016/s0140-6736(78)92182-7. [DOI] [PubMed] [Google Scholar]
- Walder M. Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents. Antimicrob Agents Chemother. 1979 Jul;16(1):37–39. doi: 10.1128/aac.16.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wright E. P. Meningism associated with Campylobacter jejuni enteritis. Lancet. 1979 May 19;1(8125):1092–1092. doi: 10.1016/s0140-6736(79)92996-9. [DOI] [PubMed] [Google Scholar]